Hundreds of thousands of Britons remain vulnerable to Covid because they have not responded to the vaccines. A drug exists which could protect them. Called Evusheld, the medicine has been rolled out in dozens of countries including the US and France. However, the UK Government refuses to fund it. This week, The Mail on Sunday launches a vital campaign to provide Britain's most vulnerable with Evusheld. The Medical Minefield team speak to Imogen Dempsey, who has been shielding since the beginning of the pandemic and desperately needs Evusheld to return to her normal life. Meanwhile, Lord Andrew Lansley, former Secretary of Health, explains why he has lobbied ministers for months to fund the drug.

<p>Hundreds of thousands of Britons remain vulnerable to Covid because they have not responded to the vaccines. A drug exists which could protect them. Called Evusheld, the medicine has been rolled out in dozens of countries including the US and France. However, the UK Government refuses to fund it. This week, The Mail on Sunday launches a vital campaign to provide Britain's most vulnerable with Evusheld. The Medical Minefield team speak to Imogen Dempsey, who has been shielding since the beginning of the pandemic and desperately needs Evusheld to return to her normal life. Meanwhile, Lord Andrew Lansley, former Secretary of Health, explains why he has lobbied ministers for months to fund the drug.</p>

Medical Minefield is a new health podcast where we talk about the ethical dilemmas at the heart of the health stories that matter the most. Join Barney Calman, the Mail on Sunday's health editor and deputy Health Editor Eve Simmons every week for a podcast tackling the big questions in health. 

<p>Medical Minefield is a new health podcast where we talk about the ethical dilemmas at the heart of the health stories that matter the most. Join Barney Calman, the Mail on Sunday's health editor and deputy Health Editor Eve Simmons every week for a podcast tackling the big questions in health.&nbsp;</p>

Advertisement